Durability is typically measured by the duration of progression-free survival (PFS) or overall survival (OS). PFS is the length of time during and after the treatment that a patient lives with the disease without it getting worse, while OS is the time from the start of treatment until death from any cause. Durability can also be assessed by the length of time a patient remains in complete remission or the time to recurrence.
